Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00243_DB00246_nanopub.RAs5oI9MJhEvTQzo7WRrHGSE9fTz1vN59z-SSBu1-_Nhs#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00243_DB00246 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00243_DB00246 label "DDI between Ranolazine and Ziprasidone - Additive QTc-prolonging effects may increase the risk of severe arrhythmias. Concomitant therapy is contraindicated. [drugbank_resource:DB00243_DB00246]" assertion.
- drugbank_resource:DB00243_DB00246 identifier "drugbank_resource:DB00243_DB00246" assertion.
- drugbank_resource:DB00243_DB00246 title "DDI between Ranolazine and Ziprasidone - Additive QTc-prolonging effects may increase the risk of severe arrhythmias. Concomitant therapy is contraindicated." assertion.
- drugbank:DB00243 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00243_DB00246 assertion.
- drugbank:DB00246 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00243_DB00246 assertion.